gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Chronic Kidney Failure in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daelemans, R; Gheuens, E; Mesens, S | 1 |
| Assogba, U; Auberton, E; Bellin, MF; Deray, G; Dion-Voirin, E; Ghany, F; Grellet, J; Jacobs, C | 1 |
| Baumelou, B; Bellin, MF; Boulechfar, H; Deray, G; Grellet, J; Jacobs, C; Rey, JP | 1 |
2 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Chronic Kidney Failure
| Article | Year |
|---|---|
Dialysability of gadoteric acid in patients with end-stage renal disease undergoing hemodialysis.
Topics: Adult; Aged; Biological Availability; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Female; Heterocyclic Compounds; Humans; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Organometallic Compounds; Patient Safety; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Gd-DOTA: evaluation of its renal tolerance in patients with chronic renal failure.
Topics: Contrast Media; Evaluation Studies as Topic; Female; Heterocyclic Compounds; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds | 1992 |
1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Chronic Kidney Failure
| Article | Year |
|---|---|
Renal tolerance of the paramagnetic contrast medium Gd-DOTA in patients with chronic renal failure.
Topics: Contrast Media; Drug Tolerance; Gadolinium; Heterocyclic Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Organometallic Compounds | 1990 |